Related Experiment Video
Updated: May 19, 2026

The Use of Pharmacological-challenge fMRI in Pre-clinical Research: Application to the 5-HT System
Published on: April 25, 2012
5-HT(1A) receptor binding changes in patients with major depressive disorder before and after antidepressant
Amélie Lothe1, Mohamed Saoud, Sandrine Bouvard
1Université de Lyon, Lyon, France. amelie.lothe@cermep.fr
Abstract:
This is the first [¹⁸F]MPPF PET study in positron emission tomography study in depressed patients, both before and after treatment with a selective serotonin reuptake inhibitor (SSRI). Dynamic changes in [¹⁸F]MPPF binding potential were observed primarily in the medial orbital regions from baseline to 30 days of treatment, suggesting SSRI-mediated serotoninergic adaptative mechanisms.
Related Concept Videos
Antidepressant Drugs: MAOIs and Other Agents
G-protein Coupled Receptors
Antidepressant Drugs: Overview
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

